BSE filing, NSE: FREDUN. Summary written from the filing by ALFA Finder's alert engine.
Fredun Pharmaceuticals Ltd: key numbers
- Share price
- ₹1,450.60
- Market cap
- ₹2,079 Cr
- Revenue (annual)
- ₹635.5 Cr
- Net profit (annual)
- ₹32.62 Cr
- P/E (TTM)
- 47.4×Sector 48.7×
- Promoter holding
- 43.62%-0.95% QoQ
- FII holding
- 0.69%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fredun Pharmaceuticals Ltd
All →Fredun Pharmaceuticals Convertible Warrants
Fredun Pharmaceuticals allotted 44,000 equity shares to three non-promoter investors on conversion of 14,667 warrants. The conversion follows the 1:2 bonus issue, which adjusted warrant entitlements.
Fredun Pharmaceuticals Other Announcement
Fredun Pharmaceuticals Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026. The disclosure provides the equity holding structure for shareholders.
Fredun Pharmaceuticals Other Announcement
Fredun Pharmaceuticals filed a compliance certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018. It confirms the processing of dematerialized shares for the quarter.
Fredun Pharmaceuticals Business Update
Fredun Pharma announces strategic pet-care acquisitions, capacity expansion, and a 100% branded portfolio target by 2029. H1 FY27 business update outlines multi-pillar growth transformation.
- manufacturing infrastructure (Palghar plant)
- 90000 sq. ft.
Fredun Pharmaceuticals Capital Structure Change
Fredun Pharmaceuticals allotted 1,82,400 equity shares upon the conversion of 60,800 warrants. The company received total consideration of ₹7.60 Crore for this warrant conversion.
- Value
- ₹7.60 Cr
Fredun Pharmaceuticals Capital Structure Change
Fredun Pharmaceuticals has allotted 1,82,400 equity shares following the conversion of 60,800 warrants into equity shares, completing the preferential issue conversion process.
Other dividend announcements
All →CARE Ratings Dividend
CARE Ratings Limited declared an interim dividend of ₹10 per equity share for the financial year 2026-2027. The record date is set for November 6, 2026.
Krishna Defence and Allied Industries Dividend
Krishna Defence board declared an interim dividend of Rs 0.75 per equity share on October 29, 2026. The record date for the dividend is November 5, 2026.
Trident Techlabs Dividend
Trident Techlabs has paid its FY2025-26 final dividend of Rs. 1 per share, approved at the 26th AGM. Some bank-rejected payments move to unpaid dividend account.
Silver Touch Technologies Dividend
Silver Touch Technologies recommended an interim dividend of ₹0.10 per equity share (5% on ₹2 face value). The record date for entitlement is November 4, 2026.
Sanofi India Dividend
Sanofi India declared an interim dividend of Rs 75 per equity share at its 29-Oct-2026 board meeting. Record date is 5-Nov-2026.
Asian Paints Dividend
Asian Paints declared an interim dividend of Rs 5.75 per equity share for FY 2026-27 at its 29 October 2026 board meeting. Record date is 04-11-2026 and payment is proposed by 13-11-2026.